Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

549 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rapid response of brain metastasis to crizotinib in a patient with ALK rearrangement-positive non-small-cell lung cancer.
Kaneda H, Okamoto I, Nakagawa K. Kaneda H, et al. J Thorac Oncol. 2013 Apr;8(4):e32-3. doi: 10.1097/JTO.0b013e3182843771. J Thorac Oncol. 2013. PMID: 23486271 No abstract available.
Combination phase I study of nedaplatin and gemcitabine for advanced non-small-cell lung cancer.
Kurata T, Tamura K, Yamamoto N, Nogami T, Satoh T, Kaneda H, Nakagawa K, Fukuoka M. Kurata T, et al. Among authors: kaneda h. Br J Cancer. 2004 Jun 1;90(11):2092-6. doi: 10.1038/sj.bjc.6601817. Br J Cancer. 2004. PMID: 15150564 Free PMC article. Clinical Trial.
Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer.
Kaneda H, Tamura K, Kurata T, Uejima H, Nakagawa K, Fukuoka M. Kaneda H, et al. Lung Cancer. 2004 Nov;46(2):247-54. doi: 10.1016/j.lungcan.2004.04.032. Lung Cancer. 2004. PMID: 15474673
A phase I study of irinotecan in combination with amrubicin for advanced lung cancer patients.
Kaneda H, Kurata T, Tamura K, Uejima H, Nakagawa K, Fukuoka M. Kaneda H, et al. Anticancer Res. 2006 May-Jun;26(3B):2479-85. Anticancer Res. 2006. PMID: 16821636 Clinical Trial.
Large cell neuroendocrine carcinoma of the mediastinum with alpha-fetoprotein production.
Takezawa K, Okamoto I, Fukuoka J, Tanaka K, Kaneda H, Uejima H, Yoon HE, Imakita M, Fukuoka M, Nakagawa K. Takezawa K, et al. Among authors: kaneda h. J Thorac Oncol. 2008 Feb;3(2):187-9. doi: 10.1097/JTO.0b013e3181623359. J Thorac Oncol. 2008. PMID: 18303442
SRPX2 is overexpressed in gastric cancer and promotes cellular migration and adhesion.
Tanaka K, Arao T, Maegawa M, Matsumoto K, Kaneda H, Kudo K, Fujita Y, Yokote H, Yanagihara K, Yamada Y, Okamoto I, Nakagawa K, Nishio K. Tanaka K, et al. Among authors: kaneda h. Int J Cancer. 2009 Mar 1;124(5):1072-80. doi: 10.1002/ijc.24065. Int J Cancer. 2009. PMID: 19065654
Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor.
Maegawa M, Arao T, Yokote H, Matsumoto K, Kudo K, Tanaka K, Kaneda H, Fujita Y, Ito F, Nishio K. Maegawa M, et al. Among authors: kaneda h. Cancer Sci. 2009 Mar;100(3):552-7. doi: 10.1111/j.1349-7006.2008.01071.x. Epub 2009 Jan 14. Cancer Sci. 2009. PMID: 19154417
mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells.
Matsumoto K, Arao T, Tanaka K, Kaneda H, Kudo K, Fujita Y, Tamura D, Aomatsu K, Tamura T, Yamada Y, Saijo N, Nishio K. Matsumoto K, et al. Among authors: kaneda h. Cancer Res. 2009 Sep 15;69(18):7160-4. doi: 10.1158/0008-5472.CAN-09-1289. Epub 2009 Sep 8. Cancer Res. 2009. PMID: 19738050
Phase I clinical and pharmacokinetic study of sorafenib in combination with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.
Okamoto I, Miyazaki M, Morinaga R, Kaneda H, Ueda S, Hasegawa Y, Satoh T, Kawada A, Fukuoka M, Fukino K, Tanigawa T, Nakagawa K. Okamoto I, et al. Among authors: kaneda h. Invest New Drugs. 2010 Dec;28(6):844-53. doi: 10.1007/s10637-009-9321-x. Epub 2009 Sep 18. Invest New Drugs. 2010. PMID: 19760364 Free PMC article. Clinical Trial.
Phase II trial of amrubicin for second-line treatment of advanced non-small cell lung cancer: results of the West Japan Thoracic Oncology Group trial (WJTOG0401).
Kaneda H, Okamoto I, Hayashi H, Yoshioka H, Miyazaki M, Kudoh S, Kimura T, Sugiura T, Sawa T, Takeda K, Iwamoto Y, Satouchi M, Akita K, Saito H, Goto I, Shibata K, Fukuoka M, Nakagawa K; West Japan Thoracic Oncology Group. Kaneda H, et al. J Thorac Oncol. 2010 Jan;5(1):105-9. doi: 10.1097/JTO.0b013e3181c07c6c. J Thorac Oncol. 2010. PMID: 19884859 Clinical Trial.
549 results
Jump to page
Feedback